E xogenous prostaglandins (PG) of the E series can suppress glucose-induced insulin secretion by pancreatic islets from rats (1), and intravenous infusion of PGE suppresses glucose-induced insulin secretion in dogs (2) and humans (3). An inhibitor of PG biosynthesis partially restores the insulin secretory response to glucose in humans with type II (non-insulin-dependent) diabetes (4), and pancreatic islets isolated from rats synthesize PGE 2 and other cyclooxygenase products from endogenous arachidonate (5). Such findings are compatible with the hypothesis that islet PGE 2 may negatively modulate glucose-induced insulin secretion (6). Arachidonate 12- lipoxygenase products, however, may amplify glucoseinduced insulin secretion (7-10). D-Glucose augments 12-lipoxygenase product accumulation in isolated rat islets (7, 8) , and pharmacologic inhibitors of the 12-lipoxygenase suppress glucose-induced insulin secretion from rat p-cells (9,10).
lipoxygenase products, however, may amplify glucoseinduced insulin secretion (7) (8) (9) (10) . D-Glucose augments 12-lipoxygenase product accumulation in isolated rat islets (7, 8) , and pharmacologic inhibitors of the 12-lipoxygenase suppress glucose-induced insulin secretion from rat p-cells (9, 10) .
Arachidonate metabolites act as local mediators rather than as circulating hormones because of their rapid catabolism, and there is considerable variation among cell types and occasionally among species in the profile of arachidonate metabolites produced (11) . The hypothesis that arachidonate metabolites modulate insulin secretion in humans would therefore be strengthened by the demonstration that biosynthesis of PGE 2 and of 12-lipoxygenase products from endogenous arachidonate occurs in isolated human pancreatic islets. We have examined this possibility and the influence of inhibitors of arachidonate metabolism on glucose-induced insulin secretion by isolated human islets. O] (MSD Isotopes) as described (12) . Isolation and culture of human islets. Pancreases were removed from three separate life-supported cadavers when other organs were obtained for transplantation. Islets were isolated from the pancreas by methods described elsewhere (13) and were cultured for 3-7 days at 24°C and for 24 h at 37°C just before use under an atmosphere of 5% CO 2 /95% air in tissue culture medium 1066 (Gibco, Grand Island, NY) containing 10% fetal bovine serum, penicillin (100 U/ml), glutamine (2 mM), and HEPES (25 mM) at pH 7. (5 mM HEPES/115 mM NaCI/24 mM NaHCO 3 /5 mM KCI/1 mM MgCI 2 /2.5 mM CaCI 2 , pH 7.4) containing glucose (3 mM) and 0.1% Pentex fraction V fatty acid-free bovine serum albumin (BSA; Miles, Naperville, IL). About 6000 islets were then handpicked under microscopic visualization, transferred to a silanized glass vial containing 1 ml of the medium, and incubated (30 min, 37°C). After removal of medium, the islets were then rinsed three times in a similar medium without BSA and suspended in KRB buffer (1 ml) containing 28 mM glucose but no BSA. ethyl acetate. The organic phase was concentrated and analyzed by HPLC. Product analysis. The following analytic procedures were performed as described in the figure legends and in previous publications (5,7,10): 7) RP-HPLC and normal-phase (NP) HPLC; 2) derivatization to the methyl ester (ME), pentafluorobenzyl ester (PFBE), methoxime (MO), and trimethylsilyl ether (TMS); and 3) gas-chromatographic (GC), negativeion chemical ionization (NICI), mass-spectrometric (MS) analyses. Islet perifusion. Five hundred isolated human islets were placed in each chamber of a dual-chamber perifusion apparatus perifused with KRB buffer (3 mM glucose, 0.1 % BSA) for 30 min at 37°C as described (14) . The glucose concentration was then increased to 16.7 mM in both chambers, and an inhibitor of arachidonate metabolism (10 |xM indomethacin or 500 |xM BW 755C) was simultaneously added to the medium of the experimental but not the control chamber. The insulin content of aliquots of the perifusion effluent was measured by radioimmunoassay.
MATERIALS AND METHODS

RESULTS
Incubation of isolated human islets with [
3 H 8 ]arachidonate generated 3 H-labeled materials with the RP-HPLC mobility of cyclooxygenase products, including PGE 2 and PGF 2a (Fig.  1 A) . These 3 H-labeled peaks were harvested separately, derivatized, and analyzed by GC-NICI-MS. The RP-HPLC peak corresponding to PGE 2 on derivatization yielded a material with the GC retention time and NICI-MS ion characteristic of authentic derivatized PGE 2 . The identity of the islet product as PGE 2 (Fig. MB) . Similar experiments with the material in the 3 H-labeled RP-HPLC peak corresponding to PGF 2o demonstrated that the peak did contain PGF 2a (Fig. 1C) . The total amounts of PGE 2 and PGF 2a recovered from the incubations were ~69 and -275 fg/islet, respectively.
The isolated human islets also converted [ 3 H 8 ] arachidonate to a 3 H-labeled product with the RP-HPLC mobility of 12-HETE ( Fig. 2A) . On extraction, conversion to the ME derivative, and NP-HPLC analysis, this material exhibited the elution position relative to standard 12-HETE-ME expected for [ 3 H 8 ]-12-HETE-ME ( Fig. 26; 5) . Products with the HPLC mobility of 5-HETE or 15-HETE were not observed. In the experiment illustrated in Fig. 2C, [ 
18
O 2 ]-12-HETE was used as an internal standard during processing of the islet products, and 12-HETE was isolated by sequential RP-HPLC as the free acid, conversion to the PFBE derivative, RP-HPLC as the PFBE, and conversion to the TMS derivative. This material was then analyzed by GC-NICI-MS, and isletderived 12-HETE was observed that coeluted with the 18 O 2 -labeled internal standard. Total human islet production of 12-HETE was 370 fg/islet in this experiment.
Human islets perifused with 16.7 mM D-glucose exhibited a brisk insulin secretory response (Fig. 3) . In preliminary experiments, the lipoxygenase/cyclooxygenase inhibitor BW 755C suppressed glucose-induced insulin secretion by human islets under these conditions (10) , and the selective cyclooxygenase inhibitor indomethacin enhanced glucoseinduced insulin secretion (Fig. 3) .
DISCUSSION
These studies establish that human islets convert .endogenous arachidonate to both cyclooxygenase and 12-lipoxygenase products and accumulate PGE 2 and 12-HETE in amounts comparable to those previously observed for freshly isolated rat islets (7) . Suppression of glucose-induced insulin secretion from isolated human islets by BW 755C adds to a growing body of evidence that 12-lipoxygenase products may serve a second-messenger function in islets (7) (8) (9) (10) . Our data are also compatible with the hypothesis that the islet cyclooxygenase product PGE 2 negatively modulates insulin secretion (6) .
Although the stereochemical composition of human islet 12-HETE has not yet been determined, rat islet 12-HETE consists exclusively of the S-stereoisomer and therefore ap-DIABETES, VOL. 37, JULY 1988 pears to be a product of the 12-lipoxygenase rather than of a cytochrome P-450 monooxygenase (unpublished observations). Human islets, like rat islets (9,10), do not appear to synthesize 5-or 15-lipoxygenase products of arachidonate. The attractiveness of the hypothesis that 12-lipoxygenase products participate in stimulus-secretion coupling in human islets is enhanced by recent evidence of such a role for 12-lipoxygenase products in other secretory cells (15) .
